National MS Society: Study Compares Disease-Modifying Therapies in People Newly Diagnosed With Multiple Sclerosis
September 12, 2026
September 12, 2026
NEW YORK, Sept. 12 (TNSjou) -- The National Multiple Sclerosis Society issued the following news:
* * *
September 11, 2026
New Study Compares Disease-Modifying Therapies in People Newly Diagnosed with Multiple Sclerosis
An international team reports that therapies that deplete immune "B cells" were significantly better than oral therapies at reducing relapses and damage on MRI scans in 455 people newly diagnosed with multiple sclerosi . . .
* * *
September 11, 2026
New Study Compares Disease-Modifying Therapies in People Newly Diagnosed with Multiple Sclerosis
An international team reports that therapies that deplete immune "B cells" were significantly better than oral therapies at reducing relapses and damage on MRI scans in 455 people newly diagnosed with multiple sclerosi . . .